Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 12:37PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
It's NOT!...confirmed multiple times by Sarah Z and the IR department of Zenith in Calgary.